2.29
price down icon5.37%   -0.13
after-market Dopo l'orario di chiusura: 2.30 0.010 +0.44%
loading
Precedente Chiudi:
$2.42
Aprire:
$2.43
Volume 24 ore:
1.15M
Relative Volume:
0.85
Capitalizzazione di mercato:
$162.61M
Reddito:
$20.76M
Utile/perdita netta:
$-132.49M
Rapporto P/E:
-0.8577
EPS:
-2.67
Flusso di cassa netto:
$-108.55M
1 W Prestazione:
+5.05%
1M Prestazione:
+46.79%
6M Prestazione:
-36.91%
1 anno Prestazione:
-61.45%
Intervallo 1D:
Value
$2.225
$2.43
Intervallo di 1 settimana:
Value
$2.145
$2.705
Portata 52W:
Value
$1.085
$7.3573

C 4 Therapeutics Inc Stock (CCCC) Company Profile

Name
Nome
C 4 Therapeutics Inc
Name
Telefono
(617) 231-0700
Name
Indirizzo
490 ARSENAL WAY, WATERTOWN
Name
Dipendente
110
Name
Cinguettio
Name
Prossima data di guadagno
2025-02-24
Name
Ultimi documenti SEC
Name
CCCC's Discussions on Twitter

Confronta CCCC con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
CCCC
C 4 Therapeutics Inc
2.29 157.64M 20.76M -132.49M -108.55M -2.67
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
472.27 120.73B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
564.64 61.80B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.00 42.46B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.74 35.22B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
296.46 31.99B 3.81B -644.79M -669.77M -6.24

C 4 Therapeutics Inc Stock (CCCC) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-12-19 Aggiornamento Wells Fargo Equal Weight → Overweight
2024-11-18 Iniziato Stephens Equal-Weight
2024-01-29 Aggiornamento JP Morgan Underweight → Neutral
2023-12-13 Aggiornamento Stifel Hold → Buy
2023-02-24 Aggiornamento Credit Suisse Underperform → Neutral
2023-02-24 Downgrade JP Morgan Neutral → Underweight
2022-11-04 Downgrade JP Morgan Overweight → Neutral
2022-10-11 Iniziato Morgan Stanley Underweight
2022-04-28 Iniziato Credit Suisse Underperform
2022-04-11 Downgrade BofA Securities Buy → Neutral
2022-03-10 Iniziato JP Morgan Overweight
2022-02-11 Ripresa BMO Capital Markets Outperform
2022-02-10 Iniziato Wells Fargo Equal Weight
2021-11-23 Iniziato BofA Securities Buy
2021-10-14 Iniziato SVB Leerink Mkt Perform
2021-09-30 Iniziato Stifel Hold
2021-06-04 Iniziato H.C. Wainwright Buy
2021-03-31 Iniziato BMO Capital Markets Outperform
2020-10-28 Iniziato UBS Buy
2020-10-27 Iniziato BMO Capital Markets Outperform
2020-10-27 Iniziato Jefferies Buy
Mostra tutto

C 4 Therapeutics Inc Borsa (CCCC) Ultime notizie

pulisher
Jul 24, 2025

C4 Therapeutics Inc. Stock Analysis and ForecastMarket-crushing stock picks - PrintWeekIndia

Jul 24, 2025
pulisher
Jul 24, 2025

What drives C4 Therapeutics Inc. stock priceMarket-beating performance - jammulinksnews.com

Jul 24, 2025
pulisher
Jul 23, 2025

What analysts say about C4 Therapeutics Inc. stockFree Technical Analysis Support - Autocar Professional

Jul 23, 2025
pulisher
Jul 22, 2025

Is C4 Therapeutics Inc. a good long term investmentExplosive capital appreciation - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 19, 2025

What analysts say about C4 Therapeutics Inc. stock outlookMinimized Risk Maximum Return - beatles.ru

Jul 19, 2025
pulisher
Jul 18, 2025

C4 Therapeutics Reports First Quarter 2025 Financial Results and Recent Business Highlights - ADVFN Brasil

Jul 18, 2025
pulisher
Jul 18, 2025

Aardvark Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(C)(4) - The Manila Times

Jul 18, 2025
pulisher
Jul 18, 2025

C4 Therapeutics Bets On New Cancer Drug And Big Partnerships - Finimize

Jul 18, 2025
pulisher
Jul 17, 2025

Molecular Glue Degrader Market Top Companies StudyC4 - openPR.com

Jul 17, 2025
pulisher
Jul 16, 2025

Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire

Jul 16, 2025
pulisher
Jul 16, 2025

Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Jul 16, 2025
pulisher
Jul 14, 2025

Marriott (MAR) names Jennifer Mason CFO as Kathleen Oberg retires | CCCC SEC FilingForm 4 - Stock Titan

Jul 14, 2025
pulisher
Jul 12, 2025

Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire

Jul 12, 2025
pulisher
Jul 11, 2025

C4 Therapeutics (CCCC) Shares Soar 12.06% on FDA Designations - AInvest

Jul 11, 2025
pulisher
Jul 11, 2025

Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - TradingView

Jul 11, 2025
pulisher
Jul 11, 2025

C4 Therapeutics Stock Surges: What Now? - StocksToTrade

Jul 11, 2025
pulisher
Jul 11, 2025

Aligos Therapeutics Grants 2,100 Shares in Stock Options to New Hires with 4-Year Vesting Terms - Stock Titan

Jul 11, 2025
pulisher
Jul 11, 2025

C4 Therapeutics, Inc. (NASDAQ:CCCC) Surges 27% Yet Its Low P/S Is No Reason For Excitement - simplywall.st

Jul 11, 2025
pulisher
Jul 11, 2025

Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance

Jul 11, 2025
pulisher
Jul 10, 2025

Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Jul 10, 2025
pulisher
Jul 10, 2025

Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire

Jul 10, 2025
pulisher
Jul 10, 2025

Crinetics Pharmaceuticals Announces July 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Yahoo Finance

Jul 10, 2025
pulisher
Jul 10, 2025

Top Penny Stocks To Watch In July 2025 - Yahoo Finance

Jul 10, 2025
pulisher
Jul 09, 2025

C4 Therapeutics (CCCC) Soars 26.90% on Positive Clinical Trial Results - AInvest

Jul 09, 2025
pulisher
Jul 07, 2025

Intellia Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Jul 07, 2025
pulisher
Jul 07, 2025

Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - PR Newswire

Jul 07, 2025
pulisher
Jul 03, 2025

Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Jul 03, 2025
pulisher
Jul 03, 2025

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Jul 03, 2025
pulisher
Jul 03, 2025

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Jul 03, 2025
pulisher
Jul 03, 2025

BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Jul 03, 2025
pulisher
Jul 02, 2025

Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire

Jul 02, 2025

C 4 Therapeutics Inc Azioni (CCCC) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$23.63
price up icon 3.32%
$36.59
price up icon 1.61%
$103.52
price up icon 0.08%
$27.57
price down icon 1.57%
$114.57
price down icon 0.03%
biotechnology ONC
$296.46
price up icon 0.55%
Capitalizzazione:     |  Volume (24 ore):